AIMT
Aimmune Therapeutics, Inc.
Chief Commercial Officer Andrew Oxtoby bought $44K of Aimmune Therapeutics, Inc.
Bought$44,266
$14.76Price
3,000Shares
+14%Stake
What AIMT did for a copier
Prices for AIMT after this filing aren't in yet.
Andrew Oxtoby's record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Mar 13. Filed Tue, Mar 17, 12:51 PM ET, during the session. Not investment advice.